Effects of HIF-1 and HIF2 on Growth and Metabolism of Clear-Cell Renal Cell Carcinoma 786-0 Xenografts
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
In cultured clear-cell renal carcinoma (CCRCC) 786-0 cells transfected with HIF1 (HIF-1+), HIF-2 (HIF-2+), or empty vector (EV), no significant differences were observed in the growth rates in vitro, but when grown in vivo as xenografts HIF-2 significantly increased, and HIF-1 significantly decreased growth rates, compared to EV tumors. Factors associated with proliferation were increased and factors associated with cell death were decreased in HIF-2+ tumors. Metabolite profiles showed higher glucose and lower lactate and alanine levels in the HIF-2+ tumors whilst immunostaining demonstrated higher pyruvate dehydrogenase and lower pyruvate dehydrogenase kinase 1, compared to control tumors. Taken together, these results suggest that overexpression of HIF-2 in CCRCC 786-0 tumors regulated growth both by maintaining a low level of glycolysis and by allowing more mitochondrial metabolism and tolerance to ROS induced DNA damage. The growth profiles observed may be mediated by adaptive changes to a more oxidative phenotype.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, in certain contexts, such as in renal cancer or medulloblastoma where HIF-1α is lost or inactivated, HIF-2α acquires the dominant role in regulating the hypoxia response, suggesting a measure of redundancy between the two isoforms [5, 6].”
From The HIF Axes in Cancer - Angiogenesis, Metabolism and Immune-Modulation (2025) · cites this paper as [6]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905 · cited 2×
“Its regulator, PDK, has been shown to be expressed in a HIF-1α dependent manner [5, 6].”
BackgroundOxygen sensing by metazoans: the central role of the HIF hydroxylase pathway.
Kaelin, W. G., & Ratcliffe, P. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.04.009 · Cited by 3,251 · cited 1×
“A further cohort (not shown in figures) of in vivo tumors confirmed the findings of HIF-1 and HIF-2 α expression as well as a similar growth pattern in the 3 tumor types.”
BackgroundPrognostic significance of morphologic parameters in renal cell carcinoma
Fuhrman, S. A., Lasky, L. C., & Limas, C. (1982) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198210000-00007 · Cited by 2,724
HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption
Papandreou, I., Cairns, R. A., Fontana, L., Lim, A. L., & Denko, N. C. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.012 · Cited by 2,267
Hypoxia, HIF1 and glucose metabolism in the solid tumour
Denko, N. C. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2468 · Cited by 1,707
Akt Stimulates Aerobic Glycolysis in Cancer Cells
Elstrom, R. L., Bauer, D. E., Buzzai, M., Karnauskas, R., Harris, M. H., Plas, D. R., Zhuang, H., Cinalli, R. M., Alavi, A., Rudin, C. M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2904 · Cited by 1,454
Differential Roles of Hypoxia-Inducible Factor 1α (HIF-1α) and HIF-2α in Hypoxic Gene Regulation
Hu, C.-J., Wang, L.-Y., Chodosh, L. A., Keith, B., & Simon, M. C. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.24.9361-9374.2003 · Cited by 1,386
Raval, R. R., Lau, K. W., Tran, M. G. B., Sowter, H. M., Mandriota, S. J., Li, J.-L., Pugh, C. W., Maxwell, P. H., Harris, A. L., & Ratcliffe, P. J. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.13.5675-5686.2005 · Cited by 940
Self-citationImage-selected in Vivo spectroscopy (ISIS). A new technique for spatially selective nmr spectroscopy
Ordidge, R. J., Connelly, A., & Lohman, J. A. B. (1986) · Journal of Magnetic Resonance (1969) · doi:10.1016/0022-2364(86)90031-4 · Cited by 811
Research works printed but not linked: 1
- 23. H. U. Bergmeyer, Methods of Enzymatic Analysis, Verlag Chemie, Weinheim, Germany, 2nd edition, 1974.
Cited by
Zou, Y., Palte, M. J., Deik, A. A., Li, H., Eaton, J. K., Wang, W., Tseng, Y.-Y., Deasy, R., Kost-Alimova, M., Dančík, V., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09277-9 · Cited by 887
Genetic and Functional Studies Implicate HIF1 α as a 14q Kidney Cancer Suppressor Gene
Shen, C., Beroukhim, R., Schumacher, S. E., Zhou, J., Chang, M., Signoretti, S., & Kaelin, W. G. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0098 · Cited by 413
Chiavarina, B., Martinez-Outschoorn, U. E., Whitaker-Menezes, D., Howell, A., Tanowitz, H. B., Pestell, R. G., Sotgia, F., & Lisanti, M. P. (2012) · Cell Cycle · doi:10.4161/cc.21643 · Cited by 80
EMT: A new vision of hypoxia promoting cancer progression
Jiang, J., Tang, Y.-L., & Liang, X.-H. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.11.8.15274 · Cited by 253
The von Hippel-Lindau Tumor Suppressor Gene: Implications and Therapeutic Opportunities
Elias, R., Zhang, Q., & Brugarolas, J. (2020) · The Cancer Journal · doi:10.1097/ppo.0000000000000480 · Cited by 205
VHL Deficiency Drives Enhancer Activation of Oncogenes in Clear Cell Renal Cell Carcinoma
Yao, X., Tan, J., Lim, K. J., Koh, J., Ooi, W. F., Li, Z., Huang, D., Xing, M., Chan, Y. S., Qu, J. Z., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0375 · Cited by 166
Genome-wide analysis reveals adaptation to high altitudes in Tibetan sheep
Wei, C., Wang, H., Liu, G., Zhao, F., Kijas, J. W., Ma, Y., Lu, J., Zhang, L., Cao, J., Wu, M., et al. (2016) · Scientific Reports · doi:10.1038/srep26770 · Cited by 162
State of the Science: An Update on Renal Cell Carcinoma
Jonasch, E., Futreal, P. A., Davis, I. J., Bailey, S. T., Kim, W. Y., Brugarolas, J., Giaccia, A. J., Kurban, G., Pause, A., Frydman, J., et al. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0117 · Cited by 162
Philip, B., Ito, K., Moreno-Sanchez, R., & Ralph, S. J. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt209 · Cited by 161
Hypoxia Inducible Factor Pathway Inhibitors as Anticancer Therapeutics
Burroughs, S. K., Kaluz, S., Wang, D., Wang, K., Van Meir, E. G., & Wang, B. (2013) · Future Medicinal Chemistry · doi:10.4155/fmc.13.17 · Cited by 140
The role of HIF1α in renal cell carcinoma tumorigenesis
Gudas, L. J., Fu, L., Minton, D. R., Mongan, N. P., & Nanus, D. M. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1180-z · Cited by 105
Hypoxia: Adapting to High Altitude by Mutating EPAS-1 , the Gene Encoding HIF-2α
Tissot van Patot, M. C., & Gassmann, M. (2011) · High Altitude Medicine & Biology · doi:10.1089/ham.2010.1099 · Cited by 119
The multifaceted von Hippel–Lindau tumour suppressor protein
Robinson, C. M., & Ohh, M. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.02.026 · Cited by 96
Choueiri, T. K., Fay, A. P., Gagnon, R., Lin, Y., Bahamón, B., Brown, V. E., Rosenberg, J. E., Hutson, T. E., Baker-Neblett, K. L., Carpenter, C. L., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0491 · Cited by 97
Non-glucose metabolism in cancer cells—is it all in the fat?
Biswas, S., Lunec, J., & Bartlett, K. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9384-6 · Cited by 91
Self-citationThe impact of hypoxia on cell death pathways
Lenihan, C. R., & Taylor, C. T. (2013) · Biochemical Society Transactions · doi:10.1042/bst20120345 · Cited by 90
The growing complexity of HIF-1α’s role in tumorigenesis: DNA repair and beyond
Rohwer, N., Zasada, C., Kempa, S., & Cramer, T. (2012) · Oncogene · doi:10.1038/onc.2012.510 · Cited by 88
Gore, M. E., & Larkin, J. (2011) · British Journal of Cancer · doi:10.1038/sj.bjc.6606084 · Cited by 85
Davis, L., Recktenwald, M., Hutt, E., Fuller, S., Briggs, M., Goel, A., & Daringer, N. (2022) · Cancers · doi:10.3390/cancers14051259 · Cited by 83
Current strategies and progress for targeting the “undruggable” transcription factors
Zhuang, J., Liu, Q., Wu, D., & Tie, L. (2022) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00852-9 · Cited by 79
Bouquerel, P., Gstalder, C., Müller, D., Laurent, J., Brizuela, L., Sabbadini, R. A., Malavaud, B. A., Pyronnet, S., Martineau, Y., Ader, I., et al. (2016) · Oncogenesis · doi:10.1038/oncsis.2016.13 · Cited by 79
New Insights into the Biology of Renal Cell Carcinoma
Li, L., & Kaelin, W. G. (2011) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2011.04.004 · Cited by 71
The emerging role of hypoxia-inducible factor-2 involved in chemo/radioresistance in solid tumors
Zhao, J., Du, F., Luo, Y., Shen, G., Zheng, F., & Xu, B. (2015) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2015.05.004 · Cited by 69
Renal Cell Carcinoma: Molecular Aspects
Kumar, A., Kumari, N., Gupta, V., & Prasad, R. (2017) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-017-0713-y · Cited by 67
Klemba, A., Bodnar, L., Waś, H., Brodaczewska, K. K., Wcisło, G., Szczylik, C. A., & Kiéda, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249492 · Cited by 66
Biswas, S., Charlesworth, P. J. S., Turner, G. D. H., Leek, R., Thamboo, P. T., Campo, L., Turley, H., Dildey, P., Protheroe, A. S., Cranston, D., et al. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs222 · Cited by 65
Self-citationThe HIF Axes in Cancer - Angiogenesis, Metabolism and Immune-Modulation
Acuña-Pilarte, K., & Koh, M. Y. (2025) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2025.06.005 · Cited by 64
Targeting HIF2 in Clear Cell Renal Cell Carcinoma
Cho, H., & Kaelin, W. G. (2016) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2016.81.030833 · Cited by 56
Allosteric inhibition of HIF-2α as a novel therapy for clear cell renal cell carcinoma
Yu, Y.-C., Yu, Q., & Zhang, X. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.09.008 · Cited by 62
Merhautová, J., Héžová, R., Poprach, A., Kovaříková, A. S., Radová, L., Svoboda, M., Vyzula, R., Demlová, R., & Slabý, O. (2015) · BioMed Research International · doi:10.1155/2015/941980 · Cited by 59
Saito, Y., Tanaka, Y., Aita, Y., Ishii, K., Ikeda, T., Isobe, K., Kawakami, Y., Shimano, H., Hara, H., & Takekoshi, K. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00035.2011 · Cited by 57
Hypoxia, pseudohypoxia and cellular differentiation
Mohlin, S., Wigerup, C., Jögi, A., & Påhlman, S. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.03.007 · Cited by 58
Targeting of stress response pathways in the prevention and treatment of cancer
Zelenka, J., Koncošová, M., & Ruml, T. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.01.007 · Cited by 56
Forristal, C. E., Brown, A. L., Helwani, F., Winkler, I. G., Nowlan, B., Barbier, V., Powell, J. A., Engler, G. A., Diakiw, S. M., Zannettino, A. C. W., et al. (2015) · Leukemia · doi:10.1038/leu.2015.102 · Cited by 53
High Altitude and Cancer Mortality
Thiersch, M., & Swenson, E. R. (2018) · High Altitude Medicine & Biology · doi:10.1089/ham.2017.0061 · Cited by 46
Zhang, Y., Wang, H., Zhang, J., Lv, J., & Huang, Y. (2013) · Cancer Science · doi:10.1111/cas.12108 · Cited by 44
Richter, S., Qin, N., Pacak, K., & Eisenhofer, G. (2013) · Advances in Pharmacology · doi:10.1016/b978-0-12-411512-5.00014-2 · Cited by 42
Hypoxia-driven cell motility reflects the interplay between JMY and HIF-1α
Coutts, A. S., Pires, I. M., Weston, L., Buffa, F. M., Milani, M., Li, J., Harris, A. L., Hammond, E. M., & Thangue, N. B. L. (2011) · Oncogene · doi:10.1038/onc.2011.188 · Cited by 41
Self-citationHypoxia-Inducible Factor-2α as a Novel Target in Renal Cell Carcinoma
W. Choi, W. S., Boland, J., & Lin, J. (2021) · Journal of Kidney Cancer and VHL · doi:10.15586/jkcvhl.v8i2.170 · Cited by 36
Sensitivity of VHL mutant kidney cancers to HIF2 inhibitors does not require an intact p53 pathway
Stransky, L. A., Vigeant, S. M., Huang, B., West, D., Denize, T., Walton, E., Signoretti, S., & Kaelin, W. G. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2120403119 · Cited by 35
Murakami, A., Wang, L., Kalhorn, S., Schraml, P., Rathmell, W. K., Tan, A. C., Nemenoff, R. A., Stenmark, K. R., Jiang, B.-H., Reyland, M. E., et al. (2017) · Oncogenesis · doi:10.1038/oncsis.2016.89 · Cited by 39
Wu, T.-K., Wei, C.-W., Pan, Y.-R., Hsu, R., Wu, C., & Yu, Y. (2019) · Scientific Reports · doi:10.1038/s41598-019-39646-9 · Cited by 38
Wohlrab, C., Kuiper, C., Vissers, M. C. M., Phillips, E., Robinson, B. A., & Dachs, G. U. (2019) · Hypoxia · doi:10.2147/hp.s201643 · Cited by 36
Evolution of the HIF targeted therapy in clear cell renal cell carcinoma
Golijanin, B., Malshy, K., Khaleel, S. S., Lagos, G., Amin, A., Cheng, L., Golijanin, D., & Mega, A. E. (2023) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2023.102645 · Cited by 36
Drug resistance in papillary RCC: from putative mechanisms to clinical practicalities
Brodziak, A., Sobczuk, P., Bartnik, E., Fiedorowicz, M., Porta, C., Szczylik, C. A., & Czarnecka, A. M. (2019) · Nature Reviews Urology · doi:10.1038/s41585-019-0233-z · Cited by 36
Wohlrab, C., Vissers, M. C. M., Phillips, E., Morrin, H., Robinson, B. A., & Dachs, G. U. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00574 · Cited by 35
Chang, E., Liu, H., Unterschemmann, K., Ellinghaus, P., Liu, S., Gekeler, V., Cheng, Z., Berndorff, D., & Gambhir, S. S. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0217 · Cited by 35
Computational Modeling of the Metabolic States Regulated by the Kinase Akt
Mosca, E., Alfieri, R. R., Maj, C., Bevilacqua, A., Canti, G. L., & Milanesi, L. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00418 · Cited by 35
1H NMR metabolomics analysis of renal cell carcinoma cells: Effect of VHL inactivation on metabolism
Čuperlović‐Culf, M., Cormier, K., Touaibia, M., Reyjal, J., Robichaud, S., Belbraouet, M., & Turcotte, S. (2015) · International Journal of Cancer · doi:10.1002/ijc.29947 · Cited by 33
Bohonowych, J. E., Peng, S., Gopal, U., Hance, M. W., Wing, S. B., Argraves, K. M., Lundgren, K., & Isaacs, J. S. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-520 · Cited by 32
Belzutifan (MK-6482): Biology and Clinical Development in Solid Tumors
Choi, W. W., Boland, J. L., Kalola, A., & Lin, J. (2023) · Current Oncology Reports · doi:10.1007/s11912-022-01354-5 · Cited by 31
Miikkulainen, P., Högel, H., Rantanen, K., Suomi, T., Kouvonen, P., Elo, L. L., & Jaakkola, P. (2017) · Cancer & Metabolism · doi:10.1186/s40170-017-0167-y · Cited by 31
UQCRH downregulation promotes Warburg effect in renal cell carcinoma cells
Luo, Y., Bengtsson, L. M., Wang, X., Huang, T., Liu, G., Murphy, S. P., Wang, C., Koren, J., Schafer, Z. T., & Lü, X. (2020) · Scientific Reports · doi:10.1038/s41598-020-72107-2 · Cited by 29
Chen, Y., Chien, L.-H., Huang, B., Chia, Y., & Chiu, H. (2016) · Nutrition and Cancer · doi:10.1080/01635581.2016.1158292 · Cited by 29
Sun, J., Tang, Q., Gao, Y., Zhang, W., Zhao, Z., Yang, F., Hu, X., Zhang, D., Wang, Y., Zhang, H., et al. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01609-8 · Cited by 27
Nagasawa, H. (2011) · Journal of Pharmacological Sciences · doi:10.1254/jphs.10r25fm · Cited by 24
Targeting HIF-2 Alpha in Renal Cell Carcinoma
Ahmed, R., & Ornstein, M. C. (2023) · Current Treatment Options in Oncology · doi:10.1007/s11864-023-01106-y · Cited by 22
Fliedner, S. M. J., Shankavaram, U. T., Marzouca, G., ELKAHLOUN, A. G., Jochmanová, I., Därr, R., Linehan, W. M., Timmers, H. J. L. M., Tischler, A. S., Papaspyrou, K., et al. (2016) · Neoplasia · doi:10.1016/j.neo.2016.07.008 · Cited by 22
Спирина, Л. В., Usynin, Y. A., Yurmazov, Z. A., Slonimskaya, E. M., Сергеевна, К. Е., & Кондакова, И. В. (2017) · Molecular Biology · doi:10.1134/s0026893317020194 · Cited by 22
Circadian lncRNA ADIRF-AS1 binds PBAF and regulates renal clear cell tumorigenesis
Brooks, R. C., Monzy, J., Aaron, B., Zhang, X., Kossenkov, A. V., Hayden, J. E., Keeney, F., Speicher, D. W., Zhang, L., & Dang, C. V. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111514 · Cited by 20
Tóth, K., Chintala, S., & Rustum, Y. M. (2014) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0000000000000012 · Cited by 17
Wang, X., Hu, J., Fang, Y., Fu, Y., Liu, B., Zhang, C., Feng, S., & Lü, X. (2022) · Cells · doi:10.3390/cells11030472 · Cited by 14
Lim, A. R., Vincent, B. G., Weaver, A. M., & Rathmell, W. K. (2021) · Cancer Gene Therapy · doi:10.1038/s41417-021-00345-1 · Cited by 13
Bellmunt, J., Pons, F., Foreshew, A., Fay, A. P., Powles, T. B., Porta, C., Bracarda, S., Lampron, M. E., Cerbone, L., Sternberg, C. N., et al. (2014) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2014.03.002 · Cited by 12
Molecular Biology of Kidney Cancer
Kaelin, W. G. (2015) · Springer eBooks · doi:10.1007/978-3-319-17903-2_3 · Cited by 12
Спирина, Л. В., Yurmazov, Z. A., Gorbunov, A. K., Usynin, E. A., Lushnikova, N. A., & Ковалева, И. В. (2020) · Cells · doi:10.3390/cells9071680 · Cited by 11
Lombardi, O., Li, R., Jabbar, F., Evans, H., Halim, S., Lima, J. D. C. C., Browning, L., Byrne, H. M., Choudhry, H., Ratcliffe, P. J., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2024.115169 · Cited by 10
The Choice of Candidates in Survival Markers Based on Coordinated Gene Expression in Renal Cancer
Apanovich, N., Апанович, П. В., Mansorunov, D., Kuzevanova, A. Y., Matveev, V. B., & Karpukhin, A. V. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.615787 · Cited by 10
Спирина, Л. В., Usynin, E. A., Yurmazov, Z. A., Slonimskaya, E. M., & Кондакова, И. В. (2017) · PubMed Central · doi:10.22034/apjcp.2017.18.11.2977 · Cited by 8
Swearson, S., Rataan, A. O., Eliason, S. L., Amendt, B. A., Zakharia, Y., Salem, A. K., Ho, T. H., & Rustum, Y. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105604 · Cited by 7
Shepherd, S. T. C., Kelly-Morland, C., Drage, S., Brady, A. F., Macwana, R., Pickering, L., Larkin, J., Hill, P., & Turajlic, S. (2025) · ESMO Open · doi:10.1016/j.esmoop.2025.105109 · Cited by 6
Song, G., Xue, S., Zhu, Y., Wu, C., & Ji, X. (2024) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-024-00828-5 · Cited by 6
The Effect of HIF‐2 α on the Development of Inflammation
Huang, J., & Zhao, D. (2025) · International Journal of Inflammation · doi:10.1155/ijin/9092758 · Cited by 6
Lu, H., Zhu, Y., Liu, W., Yan, Y., Jiang, X., Wang, Q., Zhao, Y., He, M., & Wei, M. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220829095334 · Cited by 6
HIF Pathways in Clear Cell Renal Cancer
Lombardi, O., & Mole, D. R. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.96539 · Cited by 6
Metabolism and Metabolomics by MRS
Chung, Y., Madhu, B., & Griffiths, J. R. (2015) · Wiley eBooks · doi:10.1002/9780470034590.emrstm1461 · Cited by 6
Self-citationKame, E. É., Nguemfo, E. L., Siwe‐Noundou, X., Tsakem, B., Mpondo, E. M., Ngameni, B., Assob, J. C. N., & Teinkela, J. E. M. (2022) · Journal of Complementary and Alternative Medical Research · doi:10.9734/jocamr/2022/v20i4424 · Cited by 5
Ray, S. K., & Mukherjee, S. (2024) · Current Molecular Medicine · doi:10.2174/0115665240303179240427071748 · Cited by 3
Molecular Biology of Kidney Cancer
Kaelin, W. G. (2011) · Springer eBooks · doi:10.1007/978-3-642-21858-3_3 · Cited by 3
Gossage, L. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1622-1_4 · Cited by 2
Teinkela, J. E. M., Kame, E. É., Assob, J. C. N., Ngameni, B., & Ngoupayo, J. (2023) · International Journal of Biological and Chemical Sciences · doi:10.4314/ijbcs.v17i4.31 · Cited by 1
Srivastava, A., Saraya, A., Gunjan, D., & Sharma, R. (2026) · FEBS Open Bio · doi:10.1002/2211-5463.70167 · Cited by 1
Mitochondrial changes in clear cell renal cell carcinoma: mechanisms and potential targets
Yang, J., Pan, X., Luo, X., Zheng, X., & Wang, J. (2026) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2026.153354 · Cited by 1
Kapoor, A., Lin, X., Rodriguez, D. A., Ramkairsingh, M., Xu, H., & Tang, D. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819612-0.00022-5 · Cited by 1
ESCIN MITIGATES HYPOXIA MIMICKING NCI-H23 CELLS THROUGH MODULATION OF MMPs, HIF-1α AND HIF-2α
Selvam, C. P., & Sudhandiran, G. (2020) · International Journal of Pharmacy and Pharmaceutical Sciences · doi:10.22159/ijpps.2020v12i12.39788 · Cited by 1
Teinkela, J. E. M., Pieumeu, I. F., Fokou, J. B. H., Nzodjou, T. F., Assob, J. C. N., & Nguemfo, E. L. (2023) · International Journal of Pharmacognosy and Pharmaceutical Sciences · doi:10.33545/27067009.2023.v5.i2a.124 · Cited by 1
Investigating the Role of HIF-1 and HIF-2 Transcription Factors in Multiple Myeloma
Martin, N. M. (2018) · Adelaide Research & Scholarship (AR&S) (University of Adelaide) · Cited by 1
Exploitation du métabolisme mitochondrial oxydatif dans l'éradication du mélanome métastatique
Corazao-Rozas, P. (2014) · theses.fr (ABES) · doi:10.70675/3d88f99ez2701z47dbz8852za1e300c8109e · Cited by 1
Kidney Cancer Genomics: Paving the Road to a New Paradigm of Personalized Medicine
Yousef, G. M., White, N. M. A., & Girgis, A. H. (2012) · Springer eBooks · doi:10.1007/978-94-007-5842-1_7
Peregrina, A. E. (2013) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Hypoxins effekter på tumörceller
Bihén, S. (2011) · Epsilon Archive for Student Projects (Swedish University of Agricultural Sciences)
New functions for the cellular oxygen sensor PHD3 in clear cell renal cell carcinoma
Miikkulainen, P. (2018) · UTUPub (University of Turku)
Transcriptomic profiling of VHL-dependent long noncoding RNAs in clear cell renal cell carcinoma
Samuel, J. N., & Marsden, P. A. (2018) · European Urology Supplements · doi:10.1016/s1569-9056(18)33803-x
Bailey, S. T. (2014) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/nfxr-rg33
Hypoxins effekter på tumörceller
Bithén, S. (2011)
Ordóñez-Navadijo, Á. (2014) · Biblos-e Archivo (Universidad Autónoma de Madrid)
Geist, F. (2019) · heiDOK (Heidelberg University) · doi:10.11588/heidok.00026564
Costa, A. B. F. (2022) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/5c1z-es24
Rôle de l'ectonucléotidase CD73 dans le cancer du rein
Dussault, L. (2025) · doi:10.71781/4693
Kıran, M. M. (2017) · AYBU AVESIS
Metadata
- Authors
- Biswas, S., Troy, H., Leek, R., Chung, Y.-L., Li, J.-L., Raval, R. R., Turley, H., Gatter, K., Pezzella, F., Griffiths, J. R., Stubbs, M., & Harris, A. L.
- Affiliations
- Freeman Hospital (GB)
- Institute of Cancer Research (GB)
- John Radcliffe Hospital (GB)
- St George's, University of London (GB)
- Corresponding author
- Stubbs, Marion
- ORCID
- Venue
- Journal of Oncology
- Publisher
- Hindawi Limited
- Published
- 2010
- Volume
- 2010
- Pages
- 1-14
- ISSN
- 1687-8450 (ISSN-L)
- 1687-8469
- PMC
- PMC2905950
- OpenAlex
- W1980522580
- Cited by
- 89
- References
- 46
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 2 · 2023: 4 · 2022: 8 · 2021: 4 · 2020: 7 · 2019: 5 · 2018: 5 · 2017: 7 · 2016: 6 · 2015: 6 · 2014: 7 · 2013: 6 · 2012: 7
- FWCI
- 2.32
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Journal of Oncology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PEARL (University of Plymouth) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- PEARL (University of Plymouth) (submittedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- Li Ka Shing Foundation
- Cancer Research UK (11562)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Renal cell carcinoma treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- HIF-1α, HIF-2α, clear cell renal cell carcinoma, 786-0 cells, tumor growth, xenografts, glycolysis, mitochondrial metabolism, pyruvate dehydrogenase, pyruvate dehydrogenase kinase 1, reactive oxygen species, DNA damage tolerance, glucose metabolism, lactate, alanine, cell proliferation, cell death
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.